組織因子発現の増加は,心臓アロ移植血管病の発達を予測する
Michael H Yen1, Guy Pilkington, Randall C Starling
1Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
Circulation
|September 11, 2002
まとめ
心臓移植患者の組織因子 (TF) の早期発現は,心臓アロ移植血管病 (CAV) を予測する. 高いTFレベルは,CAVリスクの増加を示し,予防のための潜在的な予後ツールを提供します.
科学分野:
- 心臓病学 心臓病学
- 免疫学 免疫学とは
- 移植医療 移植医療について
背景:
- 心臓アロ移植血管病 (CAV) は,心臓移植受容者の主要な制限です.
- 酸化脂質とフィブリン堆積量の増加は,CAVの発生率の増加と関連しています.
- 酸化脂質の影響を受けた組織因子 (TF) 発現は,CAV患者で調査されました.
研究 の 目的:
- 心臓移植を受けた患者の組織因子 (TF) 発現と心臓アロ移植血管病 (CAV) の関連性を調査する.
- TF表現がCAVの発達を予測できるかどうかを判断する.
主な方法:
- 右心生検 (RHB) の標本におけるTF発現を定量化するためのTFスコアを開発しました.
- ルーティンフォローアップを受けている63人の心臓移植患者のRHBを分析した.
- CAVの存在とTFスコアを相関させ,CAVの発症を評価するために前向きに追跡した患者.
主要な成果:
- 移植後2年以上経過した患者では,高TFスコアは,CAV患者 (75%) で,CAV患者 (26%) ではない患者よりも有意に多く見られた.
- 移植後2年未満の患者では,高いTFスコアは,CAVを発症するための78.6%のポジティブな予測値を持っていた.
- 低いTFスコアは,CAVの発展に対する100%の否定的な予測値を示した.
結論:
- 早期のTF発現は,その後のCAV発達の有意な予測因子である.
- TF発現の増加は,CAVの病理生理学において,酸化されたLDLとフィブリン堆積を結びつける可能性があります.
- TFは,CAVの予防のための予後マーカーと治療目標として機能する可能性があります.
さらに関連する動画
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
08:38A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition
Published on: July 21, 2023
関連する概念動画
01:17Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:27Development of the Heart
The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...